Martec nifedipine XL
Executive Summary
"To the best of our knowledge...Mylan has only filed and obtained tentative approval for the 30 mg" strength of nifedipine extended-release, a generic form of Pfizer's Procardia XL, Martec Scientific states in a letter to "The Pink Sheet." Mylan received tentative approval for 30 mg nifedipine XL March 15. Martec noted it has filed for 30 mg, 60 mg and 90 mg tablets, and pointed out the "exclusivity status is not fully clear" for the different strengths ("The Pink Sheet" April 5, p. 10)
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth